NBTY to Web Cast Presentation at the Goldman Sachs Global Retailing Conference; Announces Preliminary Sales for August 2005
08 Settembre 2005 - 2:30PM
PR Newswire (US)
BOHEMIA, N.Y., Sept. 8 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced that it
will web cast the presentation by Harvey Kamil, President and Chief
Financial Officer of NBTY, at the Goldman Sachs Global Retailing
Conference in New York on Friday, September 9, 2005. The conference
is being held at The Hilton New York Hotel. The presentation is
scheduled to be web cast live on the Company Web site,
http://www.nbty.com/, on Friday, September 9, 2005 at 8:10 AM
Eastern Standard Time. NBTY's preliminary unaudited sales results
for August 2005 and 2004 by segment are as follows: SALES
(Unaudited) FOR THE MONTH OF AUGUST ($ In Millions) 2005 2004 %
Change Wholesale/ US Nutrition $70 $66 7% North American Retail /
Vitamin World $19 $17 7% European Retail / Holland & Barrett /
GNC (UK) $45 $ 44 2% Direct Response/ Puritan's Pride $14 $16 -10%
Total $148 $142 4% NBTY's preliminary unaudited sales results for
the two months July and August 2005 and 2004 by segment are as
follows: SALES (Unaudited) FOR THE TWO MONTHS OF JULY AND AUGUST ($
In Millions) 2005 2004 % Change Wholesale/ US Nutrition $123 $127
-4% North American Retail / Vitamin World $38 $34 10% European
Retail / Holland & Barrett / GNC (UK) $90 $ 91 -1% Direct
Response/ Puritan's Pride $28 $31 -9% Total $279 $284 -2% ABOUT
NBTY NBTY is a leading vertically integrated manufacturer, marketer
and distributor of a broad line of high-quality, value-priced
nutritional supplements in the United States and throughout the
world. Under a number of NBTY and third party brands, the Company
offers over 19,000 products, including products marketed the
Company's Nature's Bounty(R), Vitamin World(R), Puritan's Pride(R),
Holland & Barrett(R), Rexall(R), Sundown(R), MET-Rx(R),
WORLDWIDE Sport Nutrition(R), American Health(R), GNC (UK)(R),
DeTuinen(R), LeNaturiste(TM), SISU(R) and Solgar(R) brands. This
release contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
with respect to our financial condition, results of operations and
business. These forward-looking statements can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"plan," "project," "estimate," "intend," "may," "will," "should,"
"can," or "anticipates," or the negative thereof, or variations
thereon, or comparable terminology, or by discussions of strategy.
Although all of these forward looking statements are believed to be
reasonable, they are inherently uncertain. Factors which may
materially affect such forward-looking statements include: (i) slow
or negative growth in the nutritional supplement industry; (ii)
interruption of business or negative impact on sales and earnings
due to acts of war, terrorism, bio-terrorism, civil unrest or
disruption of mail service; (iii) adverse publicity regarding
nutritional supplements; (iv) inability to retain customers of
companies (or mailing lists) recently acquired; (v) increased
competition; (vi) increased costs; (vii) loss or retirement of key
members of management; (viii) increases in the cost of borrowings
and/or unavailability of additional debt or equity capital; (ix)
unavailability of, or inability to consummate, advantageous
acquisitions in the future, including those that may be subject to
bankruptcy approval or the inability of NBTY to integrate
acquisitions into the mainstream of its business; (x) changes in
general inability of NBTY to gain and/or hold market share of its
wholesale and/or retail customers anywhere in the world; (xii)
unavailability of electricity in certain geographical areas; (xiii)
the inability of NBTY to obtain and/or renew insurance and/or the
costs of the same; (xiv) exposure to and expense of defending and
resolving, product liability claims and other litigation; (xv) the
ability of NBTY to successfully implement its business strategy;
(xvi) the inability of NBTY to manage its retail, wholesale,
manufacturing and other operations efficiently; (xvii) consumer
acceptance of NBTY's products; (xviii) the inability of NBTY to
renew leases for its retail locations; (xix) the inability of
NBTY's retail stores to attain or maintain profitability; (xx) the
absence of clinical trials for many of NBTY's products; (xxi) sales
and earnings volatility and/or trends for the Company and its
market segments; (xxii) the efficacy of NBTY's Internet and on-line
sales and marketing strategies; (xxiii) fluctuations in foreign
currencies, including the British Pound, the Euro and the Canadian
dollar; (xxiv) import-export controls on sales to foreign
countries; (xxv) the inability of NBTY to secure favorable new
sites for, and delays in opening, new retail locations; (xxvi)
introduction of and compliance with new federal, state, local or
foreign legislation or regulation or adverse determinations by
regulators anywhere in the world (including the banning of
products) and more particularly proposed Good Manufacturing
Practices in the United States, the Food Supplements Directive and
Traditional Herbal Medicinal Products Directive in Europe and
Section 404 requirements of the Sarbanes-Oxley Act of 2002; (xxvii)
the mix of NBTY's products and the profit margins thereon; (xxviii)
the availability and pricing of raw materials; (xxix) risk factors
discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; (xxx) adverse effects on NBTY as a result of increased
gasoline prices and potentially reduced traffic flow to NBTY's
retail locations; (xxxi) adverse tax determinations; (xxxii) the
loss of a significant customer of the Company; and (xxxiii) other
factors beyond the Company's control. NBTY cannot be certain that
the measures taken by the Company will be sufficient to meet the
section 404 requirements of the Sarbanes-Oxley Act of 2002. Readers
are cautioned not to place undue reliance on forward-looking
statements. NBTY cannot guarantee future results, trends, events,
levels of activity, performance or achievements. NBTY does not
undertake and specifically declines any obligation to update,
republish or revise forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrences
of unanticipated events. Consequently, such forward-looking
statements should be regarded solely as NBTY's current plans,
estimates and beliefs. Contact: Harvey Kamil Carl Hymans NBTY, Inc.
G.S. Schwartz & Co. President & Chief Financial Officer
212-725-4500 631-200-2020 DATASOURCE: NBTY, Inc. CONTACT: Harvey
Kamil, President & Chief Financial Officer of NBTY, Inc.,
+1-631-200-2020; or Carl Hymans of G.S. Schwartz & Co.,
+1-212-725-4500, Web site: http://www.nbty.com/
Copyright
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Lug 2023 a Lug 2024